Log in

Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

References

  1. Colombino M, Capone M, Lissia A, et al. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol 2012;30:2522–2529.

    Article  PubMed  Google Scholar 

  2. Chapman PB, Hauschild A, Robert C, et al. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 2011;364:2507–2516.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Sambade MJ, Peters EC, Thomas NE, Kaufmann WK, Kimple RJ, Shields JM. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011;98:394–399.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Warenius HM, Jones M, Gorman T, et al. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity. Br J Cancer 2000;83:1084–1095.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Carter S, Auer KL, Reardon DB, et al. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 1998;16:2787–2796.

    Article  CAS  PubMed  Google Scholar 

  6. Boussemart L, Boivin C, Claveau J, et al. Vemurafenib and Radiosensitization. JAMA Dermatol 2013;10:1001.

    Google Scholar 

  7. Satzger I, Degen A, Asper H, Kapp A, Hauschild A, Gutzmer R. Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy. J Clin Oncol 2013;31:e220–e222.

    Article  PubMed  Google Scholar 

  8. Ducassou A, David I, Delannes M, Chevreau C, Sibaud V. [Radiosensitization induced by vemurafenib]. Cancer Radiother 2013;17:304–307.

    Article  CAS  PubMed  Google Scholar 

  9. Anker CJ, Ribas A, Grossmann AH, et al. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol 2013;10:31.

    Google Scholar 

  10. Lee JM, Mehta UN, Dsouza LH, Guadagnolo BA, Sanders DL, Kim KB. Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report. Melanoma Res 2013;23:175–178.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caroline Robert.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baroudjian, B., Boussemart, L., Routier, E. et al. Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?. Eur J Dermatol 24, 265–267 (2014). https://doi.org/10.1684/ejd.2014.2300

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2014.2300

Keywords

Navigation